Latest news
POPULAR, INC. Q2 2026: Net income $278.2M, EPS $4.35— 10-Q Summary - TradingViewTradingView · Fri, 07 Aug 2026 20:23:58 GMTSpyGlass Pharma 2Q 2026: Net loss $(19.9)M, EPS $(0.59) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 21:22:06 GMTEvommune, Inc. 2Q 2026: Revenue $0 Net loss $53.9M — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMTImmunovant, Inc. Q1 2027: Net loss $153.2M, EPS $(0.75) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 11:31:03 GMTCION Investment Corp Q2 2026: Net income $30980 EPS $0.62— 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 10:11:01 GMTVaxcyte, Inc. Q2 2026: Net loss $(284.3M), EPS $(1.97) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 20:26:35 GMTVolitionrx - Advances Nu.Q Nets Platform Towards Commercialization - TradingViewTradingView · Thu, 30 Jul 2026 12:17:56 GMTVolition Advances Nu.Q® NETs Platform Towards Commercialization - PR NewswirePR Newswire · Thu, 30 Jul 2026 12:17:00 GMT